JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 1986; 65:1021-1028
© 1986 International Anesthesia Research Society
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shafer, A.
Right arrow Articles by White, P. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shafer, A.
Right arrow Articles by White, P. F.

Pharmacokinetics and Pharmacodynamics of Alfentanil Infusions during General Anesthesia

Audrey Shafer, MD, Man-Ling Sung, MS, and Paul F. White, Phd, MD

Department of Anesthesia, Stanford University School of Medicine, Stanford, California.

Abstract

The pharmacokinetic and pharmacodynamic properties of alfentanil were studied in 64 surgical patients. Alfentanil was administered as a loading infusion (25–130 µg/kg) followed by a maintenance infusion (0.25–1.3 µg/kg–1·min–1) as part of a nitrous oxide-narcotic-muscle relaxant technique. Although alfentanil doses of at least 50 µg/kg (in combination with thiopental, 2mg/kg) were required to prevent hemodynamic changes during intubation, apnea or chest wall rigidity frequently occurred with alfentanil loading infusions exceeding 75 µg/kg. The alfentanil clearance rate was significantly lower in patients with liver dysfunction (2.3 ± 1.3 vs 4.2 ± 2.0 ml·kg–1·min1, mean ± SD). In addition, the patients who required opioid antagonists to reverse postoperative respiratory depression had lower clearance rates (1.5 ± 0.7 vs 4.1 ± 1.9 ml·kg–1·min–1) and longer elimination half-life values (406 ± 304 vs 87 ± 53 min). For maintenance of hemodynamic stability during superficial and intraabdominal operations, alfentanil serum concentration-response curves revealed ED95 values exceeding 300 ng/ml and 400 ng/ml, respectively. Our study also demonstrated a wide range of clinical responses to fixed doses of alfentanil. At equivalent doses, some patients required supplemental anesthetics, whereas others required an opioid antagonist. Careful titration of the alfentanil maintenance infusion is recommended to minimize the possibility of postoperative respiratory depression.

Key Words: ANALGESICS—alfentanil • ANESTHETICS, INTRAVENOUS—alfentanil • PHARMACOKINETICS—alfentanil







Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1986 by the International Anesthesia Research Society.